1. This site uses cookies. By continuing to use this site, you are agreeing to our use of cookies. Learn More.
  2. Dismiss Notice

Milnacipran Study Identifies Which Fibromyalgia Patients Benefit

People with high pain and low anxiety and no major sleep problems benefit

  1. Cort
    Resource Type:
    Report or Study
    We should be seeing more of these studies over time. This data mining study found that one type of FM patient - people with
    • high pain levels
    • low anxiety or catastrophizing
    • no major sleep problems, absence of major sleeping problems
    • physical limitations in the daily life effort

    benefited most from milnacipran (Savella) - an FDA approved drug for FM. That's important because only a subset of patients benefit.